Original Research
Published on 20 Sep 2021
Dipeptidyl-Peptidase-IV Inhibitors, Imigliptin and Alogliptin, Improve Beta-Cell Function in Type 2 Diabetes
in Diabetes: Molecular Mechanisms
Frontiers in Endocrinology
doi 10.3389/fendo.2021.694390
- 5,827 views
- 6 citations


